![patty spears on Twitter: "More on barriers to clinical trial access. From Marjory Charlot @UNC_Lineberger Talked about the use of #patientnavigation (ala Freeman) to eliminate muli-level barriers for minority participation in clinical patty spears on Twitter: "More on barriers to clinical trial access. From Marjory Charlot @UNC_Lineberger Talked about the use of #patientnavigation (ala Freeman) to eliminate muli-level barriers for minority participation in clinical](https://pbs.twimg.com/media/FAIoSevXsAA7x9w.jpg:large)
patty spears on Twitter: "More on barriers to clinical trial access. From Marjory Charlot @UNC_Lineberger Talked about the use of #patientnavigation (ala Freeman) to eliminate muli-level barriers for minority participation in clinical
![Cancer clinical trials: Unleashing the power of collaboration to break the 5% participation barrier once and for all. | by Martin Naley | Pulse on Progress | Medium Cancer clinical trials: Unleashing the power of collaboration to break the 5% participation barrier once and for all. | by Martin Naley | Pulse on Progress | Medium](https://miro.medium.com/v2/resize:fit:1400/1*dT74uDG7BM2SOfXiUanSvg.png)
Cancer clinical trials: Unleashing the power of collaboration to break the 5% participation barrier once and for all. | by Martin Naley | Pulse on Progress | Medium
![Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial - The Lancet Oncology Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/c9b83dad-c11e-4068-981d-c99add3e011b/gr1.jpg)
Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial - The Lancet Oncology
![BenevolentAI on Twitter: "The latest data from @LillyPad's COV-BARRIER trial shows #baricitinib reduced deaths in #COVID19 patients by 38%. First identified by our AI in early 2020, baricitinib showed the largest reduction BenevolentAI on Twitter: "The latest data from @LillyPad's COV-BARRIER trial shows #baricitinib reduced deaths in #COVID19 patients by 38%. First identified by our AI in early 2020, baricitinib showed the largest reduction](https://pbs.twimg.com/media/EyeAQpEXIAoHJV4.jpg:large)
BenevolentAI on Twitter: "The latest data from @LillyPad's COV-BARRIER trial shows #baricitinib reduced deaths in #COVID19 patients by 38%. First identified by our AI in early 2020, baricitinib showed the largest reduction
![Eligibility Criteria a Significant Barrier to Patient Enrollment in Oncology Clinical Trials - Oncology Nurse Advisor Eligibility Criteria a Significant Barrier to Patient Enrollment in Oncology Clinical Trials - Oncology Nurse Advisor](https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2020/05/male-patient_G_1134458137.jpg)
Eligibility Criteria a Significant Barrier to Patient Enrollment in Oncology Clinical Trials - Oncology Nurse Advisor
![Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer | American Cancer Society Cancer Action Network Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer | American Cancer Society Cancer Action Network](https://www.fightcancer.org/sites/default/files/National%20Images/Resources%20Graphics/Fig%201%20Model%20Pathway%20of%20Trial%20Enrollment%20Process-th.jpg)
Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer | American Cancer Society Cancer Action Network
![Clinical Trials and Their Financial Barriers: Increasing Participation, Lowering Financial Toxicity | ASCO Connection Clinical Trials and Their Financial Barriers: Increasing Participation, Lowering Financial Toxicity | ASCO Connection](https://connection.asco.org/sites/asco_connection/files/styles/article_image/public/articles/images/Clinical-Trials-Financial-Barriers.jpg?itok=2cxxSNjT)
Clinical Trials and Their Financial Barriers: Increasing Participation, Lowering Financial Toxicity | ASCO Connection
![Doing Our Part: Improving Diversity in Clinical Research Participation - Center for Information & Study on Clinical Research Participation Doing Our Part: Improving Diversity in Clinical Research Participation - Center for Information & Study on Clinical Research Participation](https://www.ciscrp.org/wp-content/uploads/2021/03/Picture1-1.png)